Navigation Links
Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial Results
Date:2/6/2013

r of 2012 was also partly attributable to increased minimum annual sublicensing revenue from DAS.

Research and development expenses were $9.3 million for the fourth quarter of 2012, compared to $7.9 million for the same period in 2011. The increase in research and development expenses for the fourth quarter of 2012 was primarily related to the increase in external research expenses associated with our preclinical programs, partially offset by lower clinical trials and manufacturing expenses for our SB-728-T HIV/AIDS program.  General and administrative expenses were $3.0 million for the fourth quarter of 2012 and $3.2 million for the same period in 2011.

Total operating expenses for the fourth quarter of 2012 were $12.3 million, compared to $11.1 million for the same period in 2011. 

Full Year Results
For the year ended December 31, 2012, the consolidated net loss was $22.3 million, or $0.42 per share, compared to a consolidated net loss of $35.8 million, or $0.71 per share, for the year ended December 31, 2011.  Revenues were $21.7 million in 2012, compared to $10.3 million in 2011, with the increase primarily due to Sangamo's collaboration agreement with Shire. Total operating expenses were $43.9 million for 2012 and $46.1 million for 2011.

Recent Events

  • The Company Provided a Comprehensive Overview of its ZFP Therapeutic® Development Programs at its December 6, 2012 Analyst and Investor Briefing. Sangamo's management team provided an update on the Company's technology platform advancements and pipeline of ZFP Therapeutics® as well as near- and mid-term operating and financial goals during an Analyst and Investor Briefing on December 6, 2012. A webcast of the presentation can be accessed Company's website in the Investor section under Events and Presentations.
  • Presentation of Data Demonstrating a Disruptive and Broadly Lever
    '/>"/>

  • SOURCE Sangamo BioSciences, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Sangamo BioSciences to Webcast Analyst Briefing on Thursday, December 6, 2012
    2. Sangamo BioSciences Reports Second Quarter 2012 Financial Results
    3. Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013
    4. Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results
    5. Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
    6. IntelliCell BioSciences Receives Notice of Allowance for its US Patent for "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells"
    7. Regado Biosciences, Inc. to Present at the Oppenheimer 23rd Annual Healthcare Conference in New York, NY
    8. Pressure BioSciences Announces Conversion of All Remaining Series E Convertible Preferred Stock by Ironridge BioPharma
    9. Neurocrine Biosciences To Present At Deutsche Banks 2012 dbAccess BioFEST
    10. Pressure BioSciences Partners with Constant Systems to Significantly Expand Product Offerings and International Distribution
    11. Pressure BioSciences, Inc. to Discuss Third Quarter 2012 Financial Results and Provide Business Update
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/22/2014)... 22, 2014  For many people experiencing issues ... facing the prospect of large, painful incisions and ... activities are also impacted, such as working, driving ... the problem, some patients even delay necessary treatment, ... lead to permanent damage for some conditions. ...
    (Date:9/22/2014)... 22, 2014  CorMedix Inc. (NYSE MKT: CRMD), ... therapeutic products for the prevention and treatment of ... announce that TUV-SUD and The Medicinal Evaluation Board ... has granted its request for a label expansion ... initially approved in July 2013 for use in ...
    (Date:9/22/2014)... -- Thoratec Corporation (NASDAQ: THOR ), a ... save, support and restore failing hearts, announced today that ... and Chief Executive Officer, effective immediately.  Mr. Grossman succeeds ... his executive and Board roles but will remain as ... of 2016.  Mr. Grossman has served ...
    Breaking Medicine Technology:Phoenix Arizona Hand Doctor Develops Revolutionary New Surgery System, Eliminates Need for Large Incisions 2Neutrolin Label Expansion Approved for the European Union 2Neutrolin Label Expansion Approved for the European Union 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 2Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 4Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 5
    ...  Merrimack Pharmaceuticals, Inc. announced today that the first ... clinical study combining MM-121, a fully human monoclonal ... irinotecan (Camptosar®) in patients with advanced cancers. ... The Phase 1 study evaluates the safety and ...
    ... Md., Dec. 13, 2011 The U.S. Food and ... device intended to aid in the detection of life-threatening ... spectroscopy. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... health care providers identify patients with critical head injuries ...
    Cached Medicine Technology:Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121 in Combination with Cetuximab and Irinotecan in Patients with Advanced Cancers 2FDA Permits Marketing of the First Hand-Held Device To Aid in the Detection of Bleeding In The Skull 2FDA Permits Marketing of the First Hand-Held Device To Aid in the Detection of Bleeding In The Skull 3
    (Date:9/22/2014)... South Asians living in Canada have a higher rate ... compared with while people, McMaster researchers have found. ... Canadian Medical Association Journal (CMAJ Open) and may ... the fastest-growing ethnic groups in the country is the ... Canada, comprising about three percent of the population. They ...
    (Date:9/22/2014)... -- Recent two-generation approaches to reducing poverty that ... attention from researchers, advocates, and foundations. By combining ... to move to jobs that offer a path ... education for children, these programs aim to improve ... to a new report from the National Center ...
    (Date:9/22/2014)... UK (PRWEB) September 22, 2014 The ... in the recent years. The statistically important data received ... safety of cancer vaccines. The primary challenge to the ... information about the exact mechanism of how a human’s ... to various results in different individuals owing to known ...
    (Date:9/22/2014)... MONDAY, Sept. 22, 2014 (HealthDay News) -- Scans ... they learn to read. This finding could potentially ... other reading difficulties early on, preliminary research suggests. ... in children with dyslexia as well as most ... Hoeft, an associate professor of child and adolescent ...
    (Date:9/22/2014)... (PRWEB) September 22, 2014 CareFlight ... has taken delivery of a new AS365 N3+ Dauphin, ... helicopter. The new aircraft, which is based at ... all-Dauphin fleet of four air medical transport helicopters. , ... said Candy Skidmore, Premier Health Vice President, Emergency, Trauma, ...
    Breaking Medicine News(10 mins):Health News:Higher risk of heart disease for South Asians in Canada 2Health News:A two-generation lens: Current state policies fail to support families with young children 2Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 2Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 3Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 4Health News:Can Brain Scans Help Predict Young Children's Reading Abilities? 2Health News:Miami Valley Hospital CareFlight begins Service with AS365 N3+ 2Health News:Miami Valley Hospital CareFlight begins Service with AS365 N3+ 3
    ... 24 Catholic Charities,USA today urged Congress and ... come together to pass a comprehensive children,s health,insurance ... to vote on a compromise bill to,reauthorize the ... program that provides health insurance coverage to poor,children. ...
    ... and S.E.VEN, BOSTON, Sept. 24 Small Army, ... a cure for diabetes and,alleviating world poverty to their ... and S.E.VEN. "As communicators, we welcome the challenge ... dollars, but by a commitment,to truly make the world ...
    ... to Execute and Completeness of Vision, ANDOVER, ... management (IAM) solutions are the most widely implemented ... in the Visionaries,quadrant by Gartner, Inc. in the ... of the Magic Quadrant for User Provisioning, 2H07,(authored ...
    ... a,leading technology provider of mobile enterprise solutions for ... NASDAQ Stock,Market LLC has approved its application for ... Capital Market. Trading in the Company,s common stock,commenced ... the symbol "IFLG." (Logo: http://www.newscom.com/cgi-bin/prnh/20060209/PHTH052LOGO ...
    ... CHASKA, Minn., Sept. 24 Tired? Stressed? ... restore, and rejuvenate? The Village Company,( http://www.thevillagecompany.com ... bath,and body products, announces the nationwide launch ... relief from common ailments,( http://www.thevillagecompany.com/vntherapy.html ). ...
    ... Novo Nordisk, a,world leader in diabetes care, ... the Dow Jones Sustainability World Index (DJSI World) ... 18 global supersectors,analyzed. The latest global analysis ... analysis of companies, economic, environmental and,social performance, assessing ...
    Cached Medicine News:Health News:Catholic Charities USA Calls on Congress and the President to Protect the Health of Children; Urges President Not to Veto Vitally Important Bill 2Health News:Catholic Charities USA Calls on Congress and the President to Protect the Health of Children; Urges President Not to Veto Vitally Important Bill 3Health News:Small Army Takes on Cure for Diabetes and New Approach to Ending World Poverty with Addition of Non-Profit Accounts 2Health News:Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firm's User Provisioning Magic Quadrant 2Health News:Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firm's User Provisioning Magic Quadrant 3Health News:InfoLogix Announces Approval for NASDAQ Listing 2Health News:InfoLogix Announces Approval for NASDAQ Listing 3Health News:The Village Company Unveils Natural Bath and Body Solutions for Everyday Ailments 2Health News:Novo Nordisk Ranks Supersector Leader in the 2007 Dow Jones Sustainability Indexes 2
    ... of fibre bronchoscopy: The HF-compatible V series ... other fibre bronchoscopes are measured., ,The ... including the FB-19TV, FB-18V and FB-15V models ... the pediatric FB-8V, offer much better image ...
    ... High performance fiberoptic imaging from ... ,Olympus has improved its fiberscope range, ... specifications and enhanced image performance. Olympus ... instruments for diagnosis and therapy in ...
    ... performance fiberoptic imaging from the latest ... improved its fiberscope range, focussing on ... enhanced image performance. Olympus has a ... diagnosis and therapy in the respiratory ...
    Slim bronchoscope designed for paediatric applications....
    Medicine Products: